ArticlePloS one2023

Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.

Aashna Karbhari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.